EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Metabolomics‐driven approaches for identifying therapeutic targets in drug discovery

Shanshan Pan iD, Luan Yin, Jie Liu, Jie Tong, Zichuan Wang, Jiahui Zhao, Xuesong Liu, Yong Chen, Jing Miao, Yuan Zhou, Su Zeng, Tengfei Xu

MedComm · 2024-11 · 5 (11)

DOI: 10.1002/mco2.792 ↗

At a glance

Übersichtsarbeit in MedComm, published online on 2024-11-11. Written by Shanshan Pan and 11 co-authors. Institution: Research Center for Clinical Pharmacy College of Pharmaceutical Sciences Zhejiang University Hangzhou Zhejiang China. Cited 45 times so far (Crossref); 339 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Identification of therapeutic targets can directly elucidate the mechanism and effect of drug therapy, which is a central step in drug development. The disconnect between protein targets and phenotypes under complex mechanisms hampers comprehensive target understanding. Metabolomics, as a systems biology tool that captures phenotypic changes induced by exogenous compounds, has emerged as a valuable approach for target identification. A comprehensive overview was provided in this review to illustrate the principles and advantages of metabolomics, delving into the application of metabolomics in target identification. This review outlines various metabolomics‐based methods, such as dose–response metabolomics, stable isotope‐resolved metabolomics, and multiomics, which identify key enzymes and metabolic pathways affected by exogenous substances through dose‐dependent metabolite–drug interactions. Emerging techniques, including single‐cell metabolomics, artificial intelligence, and mass spectrometry imaging, are also explored for their potential to enhance target discovery. The review emphasizes metabolomics' critical role in advancing our understanding of disease mechanisms and accelerating targeted drug development, while acknowledging current challenges in the field.

Subjects

Author keywords

artificial intelligencedrug developmentmetabolomicssingle‐cell metabolomicstarget identification

Authors and institutions

  • Research Center for Clinical Pharmacy College of Pharmaceutical Sciences Zhejiang University Hangzhou Zhejiang China.
  • College of Pharmaceutical Sciences Zhejiang University Hangzhou Zhejiang China.
  • Department of Radiology and Biomedical Imaging PET Center Yale School of Medicine New Haven Connecticut USA.
  • School of Basic Medical Sciences Zhejiang Chinese Medical University Hangzhou China.
  • Cangnan County Qiushi Innovation Research Institute of Traditional Chinese Medicine Wenzhou Zhejiang China.

ORCID profiles: Shanshan Pan

Cite

APA

Pan, S., Yin, L., Liu, J., Tong, J., Wang, Z., Zhao, J., Liu, X., Chen, Y., Miao, J., Zhou, Y., Zeng, S., & Xu, T. (2024). Metabolomics‐driven approaches for identifying therapeutic targets in drug discovery. MedComm, 5(11). https://doi.org/10.1002/mco2.792

Vancouver

Pan S, Yin L, Liu J, Tong J, Wang Z, Zhao J, et al. Metabolomics‐driven approaches for identifying therapeutic targets in drug discovery. MedComm. 2024;5(11). doi:10.1002/mco2.792

BibTeX
@article{Pan2024,
  author = {Pan, Shanshan and Yin, Luan and Liu, Jie and Tong, Jie and Wang, Zichuan and Zhao, Jiahui and Liu, Xuesong and Chen, Yong and Miao, Jing and Zhou, Yuan and Zeng, Su and Xu, Tengfei},
  title = {Metabolomics‐driven approaches for identifying therapeutic targets in drug discovery},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {11},
  doi = {10.1002/mco2.792}
}
Start for free →